Medicare Enrolled
Dr. Salma Mannan-Hilaly, MD
Family Medicine · Belleville, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mannan-Hilaly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mannan-Hilaly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mannan-Hilaly
Dr. Salma Mannan-Hilaly is a family medicine specialist in Belleville, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Mannan-Hilaly performed 1,132 Medicare services across 737 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mannan-Hilaly received a total of $16,519 from 60 pharmaceutical and/or device companies across 1331 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mannan-Hilaly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 22% volume in IL
$16,519 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,132
Medicare services
Top 22% in IL for family medicine
737
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
505 | $84 | $219 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
173 | $59 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
156 | $126 | $236 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
68 | $1 | $5 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
44 | $0 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
35 | $10 | $58 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
30 | $72 | $88 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
30 | $30 | $49 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
26 | $282 | $363 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
26 | $30 | $49 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $40 | $90 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
13 | $159 | $338 |
| Respiratory virus detection test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus and influenza viruses. |
11 | $30 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,519
Total received (2018-2024)
Avg $2,360/year across 7 years
Top 2% in IL for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,331
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,519 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,732
2023
$2,478
2022
$2,134
2021
$2,298
2020
$1,955
2019
$2,595
2018
$2,327
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$607
PFIZER INC.
$354
ABBVIE INC.
$280
Abbott Laboratories
$259
Novo Nordisk Inc
$232
Janssen Pharmaceuticals, Inc
$164
Novartis Pharmaceuticals Corporation
$160
Amgen Inc.
$93
Otsuka America Pharmaceutical, Inc.
$56
Astellas Pharma US Inc
$55
GlaxoSmithKline, LLC.
$54
Axsome Therapeutics, Inc.
$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$45
Lilly USA, LLC
$43
Sumitomo Pharma America, Inc.
$41
Lundbeck LLC
$40
Paratek Pharmaceuticals, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$22
Esperion Therapeutics, Inc.
$21
CSL Behring
$20
SANOFI-AVENTIS U.S. LLC
$20
Verity Pharmaceuticals Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Azurity Pharmaceuticals, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,776
PFIZER INC.
$2,021
Janssen Pharmaceuticals, Inc
$1,813
Novo Nordisk Inc
$1,593
Abbott Laboratories
$1,167
ABBVIE INC.
$1,081
Lilly USA, LLC
$743
Amgen Inc.
$591
AbbVie Inc.
$467
Teva Pharmaceuticals USA, Inc.
$375
Allergan, Inc.
$318
Novartis Pharmaceuticals Corporation
$287
Biohaven Pharmaceutical Holding Company Ltd.
$284
GlaxoSmithKline, LLC.
$280
SANOFI-AVENTIS U.S. LLC
$229
Regeneron Healthcare Solutions, Inc.
$215
Boehringer Ingelheim Pharmaceuticals, Inc.
$207
Astellas Pharma US Inc
$189
Dexcom, Inc.
$144
Takeda Pharmaceuticals U.S.A., Inc.
$143
Amarin Pharma Inc.
$118
Sumitomo Pharma America, Inc.
$113
Mannkind Corporation
$113
Otsuka America Pharmaceutical, Inc.
$97
Bayer HealthCare Pharmaceuticals Inc.
$92
Paratek Pharmaceuticals, Inc.
$72
Lundbeck LLC
$56
Allergan Inc.
$53
Biohaven Pharmaceuticals, Inc.
$52
MannKind Corporation
$50
Merck Sharp & Dohme Corporation
$50
Zyla Life Sciences
$47
Axsome Therapeutics, Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$47
Eisai Inc.
$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$45
Kowa Pharmaceuticals America, Inc.
$41
ITI, Inc.
$41
Nestle HealthCare Nutrition Inc.
$34
Sunovion Pharmaceuticals Inc.
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
AbbVie, Inc.
$29
SANOFI PASTEUR INC.
$22
Esperion Therapeutics, Inc.
$21
Exact Sciences Corporation
$21
CSL Behring
$20
Verity Pharmaceuticals Inc.
$20
Almatica Pharma LLC
$17
Currax Pharmaceuticals LLC
$16
Shire North American Group Inc
$16
Genentech USA, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
DEXCOM, INC.
$15
Acerus Pharmaceuticals Corporation
$15
IDORSIA PHARMACEUTICALS US INC
$15
Synergy Pharmaceuticals Inc
$14
Edwards Lifesciences Corporation
$14
Hikma Pharmaceuticals USA
$14
IBSA Pharma Inc.
$13
Horizon Pharma plc
$11
Top 3 companies account for 40.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AFREZZA · AIRSUPRA · AJOVY · ANORO · AREXVY · AUSTEDO · Aimovig · Amitiza · Auvelity · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CAPLYTA · CHANTIX · COMIRNATY · CONTRAVE · CREON · Cologuard Collection Kit · Creon · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dayvigo · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GEMTESA · GRALISE · Haegarda · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NURTEC ODT · NUZYRA · Natesto · OFEV · Otezla · Ozempic · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Ryaltris · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · SYMBICORT · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Tlando · Tresiba · Trintellix · Trulance · UBRELVY · VESICARE · VIBERZI · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · Xultophy 100/3.6 · ZENPEP · ZORVOLEX · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in IL.
Geographic Context
Family medicine physicians within 10 mi
493
Per 100K population
193.5
County median income
$70,178
Nearest hospital
MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mannan-Hilaly is a clinical cardiology specialist, with above-average Medicare volume (top 22% in IL), with low-engagement industry engagement in the top 2% of IL peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mannan-Hilaly experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mannan-Hilaly performed 505 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mannan-Hilaly receive payments from pharmaceutical companies?
Yes. Dr. Mannan-Hilaly received a total of $16,519 from 60 companies across 1,331 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mannan-Hilaly's costs compare to other family medicine physicians in Belleville?
Dr. Mannan-Hilaly's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mannan-Hilaly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Belleville
Browse family medicine physicians in Belleville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in IL
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in IL
Which IL family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology